Drug intelligence / Profile preview

CadiFlu-S

Development stage: Unknown
Lead developer: CPL Biologicals
Modality: Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

**CadiFlu-S** is a recombinant, trivalent seasonal influenza **virus-like particle vaccine** developed by CPL Biologicals, a Cadila Pharmaceuticals/Novavax joint venture. It contains influenza-virus-like particles incorporating hemagglutinin, neuraminidase, and matrix protein 1 antigens from two influenza A subtypes and one influenza B lineage. The nonreplicating VLPs mimic viral structure without containing viral genetic material, stimulating protective humoral immune responses against included influenza strains. It is supplied as a 0.5 mL intramuscular injection for prevention of seasonal influenza. ([cdsco.gov.in](https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadSmPC/Cadiflu%20-S%20SmPC%20%28Trivalent%20Influenza%29.pdf))

Brand names: CadiFlu-S

Beyond the preview

Go deeper on CadiFlu-S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CadiFlu-S.

Explore the full profile